Although several studies have demonstrated prognostic significance of PD-L1 expression on tumor cells and/or immune cells in bladder cancer [15, 16], there have been only a few reports regarding the effects of BCG treatment on PD-L1 expression in bladder cancer [13, 14]. This evidence concerns the gene CD274 and urinary bladder cancer.